Evidence of neurodegeneration in autism spectrum disorder

被引:65
|
作者
Kern J.K. [1 ,2 ]
Geier D.A. [1 ]
Sykes L.K. [3 ]
Geier M.R. [1 ]
机构
[1] Institute of Chronic Illnesses, Incorporation, Silver Spring, MD
[2] University of Texas, Southwestern Medical Center at Dallas, Dallas, TX
[3] CoMeD, Incorporation, Silver Spring, MD
关键词
Autism; Autism spectrum disorder (ASD); Cytokines; Microglia; Neurodegeneration; Neuronal cell loss; Oxidative stress; Regression;
D O I
10.1186/2047-9158-2-17
中图分类号
学科分类号
摘要
Autism spectrum disorder (ASD) is a neurological disorder in which a significant number of children experience a developmental regression characterized by a loss of previously-acquired skills and abilities. Loss of neurological function in ASD, as observed in affected children who have regressed, can be explained as neurodegeneration. Although there is research evidence of neurodegeneration or progressive encephalopathy in ASD, the issue of neurodegeneration in ASD is still under debate. Evidence of neurodegeneration in the brain in ASD includes: (1) neuronal cell loss, (2) activated microglia and astrocytes, (3) proinflammatory cytokines, (4) oxidative stress, and (5) elevated 8-oxo-guanosine levels. The evidence from this review suggests that neurodegeneration underlies the loss of neurological function in children with ASD who have experienced regression and loss of previously acquired skills and abilities, and that research into treatments to address the issue of neurodegeneration in ASD are warranted. © 2013 Kern et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [1] Bumetanide for autism spectrum disorder: Current evidence
    Copur, Mazlum
    Copur, Sidar
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2020, 23 (04): : 524 - 525
  • [2] Evidence Based Treatments of Autism Spectrum Disorder
    Alateeqi, Nahed
    Janjua, Maria Fatima
    PSYCHIATRIC ANNALS, 2019, 49 (03) : 115 - 119
  • [3] Evidence Base Update for Autism Spectrum Disorder
    Smith, Tristram
    Iadarola, Suzannah
    JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY, 2015, 44 (06): : 897 - 922
  • [4] Psychopharmacology of Autism Spectrum Disorder: Evidence and Practice
    Siegel, Matthew
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 21 (04) : 957 - +
  • [5] Evidence of Assortative Mating in Autism Spectrum Disorder
    Connolly, Siobhan
    Anney, Richard
    Gallagher, Louise
    Heron, Elizabeth A.
    BIOLOGICAL PSYCHIATRY, 2019, 86 (04) : 286 - 293
  • [6] Aging and autism spectrum disorder: Evidence from the broad autism phenotype
    Wallace, Gregory L.
    Budgett, Jessica
    Charlton, Rebecca A.
    AUTISM RESEARCH, 2016, 9 (12) : 1294 - 1303
  • [7] Evidence Based Interventions for Autism Spectrum Disorder.
    Bhuyan, Dhrubajyoti
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S74 - S74
  • [8] No evidence of reaction time slowing in autism spectrum disorder
    Ferraro, F. Richard
    AUTISM, 2016, 20 (01) : 116 - 122
  • [9] Evidence of Reduced Global Processing in Autism Spectrum Disorder
    Rhonda D. L. Booth
    Francesca G. E. Happé
    Journal of Autism and Developmental Disorders, 2018, 48 : 1397 - 1408
  • [10] Evidence-Based Treatments for Autism Spectrum Disorder
    Politte L.C.
    Howe Y.
    Nowinski L.
    Palumbo M.
    McDougle C.J.
    Current Treatment Options in Psychiatry, 2015, 2 (1) : 38 - 56